Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin for Immune Activation in HIV-1 Infected Subjects on ART
NCT01969058Phase 2Completed
- Start
- Jul 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of isotretinoin in human immunodeficiency virus type 1 infection (HIV-1). Started Jul 2014; status: completed.
02
Drugs
isotretinoin
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01969058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969058.